Nuclear Imaging Market Worth $2.2 Billion by 2020 for PET & SPECT Equipment Industry

DALLAS, May 1, 2015 /PRNewswire/ --

Market Research Report "MediPoint: Nuclear Imaging - PET and SPECT Equipment - Global Analysis and Market Forecasts" says Japan and China will present the greatest opportunities for growth, with respective market shares increasing by 75% and almost 100% during the forecasted period.

Complete report on the nuclear imaging market of PET and SPECT equipments spread across 318 pages providing 11 product profiles, 14 company profiles, 91 tables and 42 figures is available at http://www.rnrmarketresearch.com/medipoint-nuclear-imaging-pet-and-spect-equipment-global-analysis-and-market-forecasts-market-report.html

This nuclear imaging market report on PET and SPECT equipments states, that, while the US market will remain steady at around $1.15 billion throughout the forecast period, the country will see its global share fall from 69% in 2013 to 53% by 2020. Meanwhile, the Asia-Pacific (APAC) region will see its share rise from 16% to 29% over the same time frame. The research examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report.

The SPECT and SPECT/CT market is a bigger market than the PET, PET/CT and PET/MRI, because the instruments have been in longer use, are cheaper, and have become the common technique for a wide range of indications. Physicians believe more and more SPECT procedures will be replaced by PET procedures. New developments in hybrid nuclear imaging promise to further increase the utility of hybrid nuclear imaging, while significantly improving patient cost-savings and safety, through reduced need for repeat examinations. This report focuses on the current and future industry trends within the nuclear medicine market, as well as discussing the promising pipeline products, and assessing the competitive landscape.

Product profiles for Brain Biosciences CerePET, ECORAD Dual Modality Imager, FMI Technologies ScintiStar PET/CT, IntraMedical Imaging Marginator Beta Camera, INSERT SPECT/MRI, Nucare/Zecotek Photonics New Generation PET Scanning Device, Philips Healthcare PET Alpha Ring Detector, Photo Diagnostic Systems NeuroPET/CT, SynchroPET Breast PET/MRI, SynchroPET Wrist Scanner and SurgicEye SPECT Hybrid are covered in this research. Companies profiles for DDD-Diagnostic, Digirad, GE Healthcare, GVI Medical Devices, Mediso Medical Imaging Systems, NeuroLogica, Neusoft Medical Systems, NuCare Medical Systems, Oncovision, Philips Healthcare, Shimadzu, Siemens Healthcare, SurgicEye and Toshiba Medical are provided in this report available for purchase at http://www.rnrmarketresearch.com/contacts/purchase?rname=250491

Questions answered by this report include what is the current and future nuclear imaging market outlook in the developed and emerging markets? What trends are affecting the global market for both SPECT and PET imaging systems? Which are the key, high growth markets that manufacturers should seek to expand into? What are the types of products that are most likely to succeed?  How many Nuclear Imaging Procedures are carried out in each of the 10 Major Markets? What does this imply for instrument adoption rates? What are the major unmet needs in nuclear imaging? In which areas can manufacturers help meet that need? What factors most influence a physician or hospital in the purchase of new nuclear imaging equipment? How much can a physician influence purchasing decisions? How will reimbursement changes affect nuclear imaging? How has the Affordable Care Act affected nuclear imaging? How will it affect it in the future? How well are new paradigms in nuclear imaging perceived? What motivates companies to develop a new nuclear imaging modality; physician demand or legislative requirement?

This research highlights that nuclear imaging market is growing moderately with a CAGR of 3.3% for the period to 2020. BIC nations will experience the highest growth rates in nuclear imaging equipment during the forecast period. Non-PET nuclear imaging procedures in the developed markets (US, 5EU, Japan) are likely overall to fall during forecast period, as a result of increasing reimbursement pressures and new technologies. PET imaging procedures in all markets likely to increase during the forecast period, despite reimbursement pressures, due to increased number of indications.

Explore more reports on the PET market and other related research on the Computed Tomography (CT) market available with RnRMarketResearch.com at http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/medical-imaging/computed-tomography-ct

About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:  

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed

Market Research Blog: http://www.rnrmarketresearch.com/blog/

Contact:

Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441

[email protected]

SOURCE RnR Market Research